Drugs / rgp120/HIV-1MN
last change Jan 1999 re-read 3 minutes ago

rgp120/HIV-1MN

Developed for
HIV infectious disease
Investigated by
Biocine · Genentech, Inc. · National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00000774 ? → Jan 1999 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as rgp120/HIV-1MN ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000774 ↗